Concepedia

Silvio Dionisotti

SD

Statistics

Publications

31

Citations

1.7K

H-Index

24

Active since

1988

Affiliations

University of Ferrara(Current)

San Raffaele University of Rome

Istituto Superiore di Sanità

Karolinska Institutet

Silvio Dionisotti is an author at University of Ferrara specializing in pharmacology, receptor pharmacology, and medicine.

Publications per year

1988–2009

31

Publications

31

The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist.

Cristina Zocchi, E. Ongini, Andrea Conti et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 197 citations

Medicine, Medicinal Chemistry, Pharmacology +10

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

E. Ongini, Silvio Dionisotti, Stefania Gessi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1999 · 185 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine Derivatives: Potent and Selective A<sub>2A</sub>Adenosine Antagonists

Pier Giovanni Baraldi, Barbara Cacciari, Giampiero Spalluto et al. · Journal of Medicinal Chemistry · 1996 · 112 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Binding of the radioligand [<sup>3</sup>H]‐SCH 58261, a new non‐xanthine A<sub>2A</sub> adenosine receptor antagonist, to rat striatal membranes

Cristina Zocchi, Ennio Ongini, S. D. Ferrara et al. · British Journal of Pharmacology · 1996 · 84 citations · Full text

Medicine, Neuroscience, Pharmacology +15

Synthesis of new pyrazolo[4,3-e]1,2,4-triazolo[1,5-c] pyrimidine and 1,2,3-triazolo[4,5-e]1,2,4-triazolo[1,5-c] pyrimidine displaying potent and selective activity as A2a adenosine receptor antagonists.

Pier Giovanni Baraldi, Stefano Manfredini, Daniele Simoni et al. · Bioorganic & Medicinal Chemistry Letters · 1994 · 83 citations

Pharmacy, Medicinal Chemistry, Pharmacology +13

1–5 of 31